The following is a near-term observation going into year-end and possibly early to mid-January 2018.


In light of the Russell 2000 Small Cap index’s recent successful test of support in the vicinity of 1452 and its strong internal readings on 11/16/17, the odds favor a near-term period of outperformance by the Small Cap universe relative to the technology-heavy Large Cap universe.   

The chart below depicts the relationship between the iShares Core S&P Small Cap ETF (IJR/$74.63)* and the PowerShares QQQ (QQQ/$153.95)*. When the line is rising, as it is now, IJR is outperforming QQQ—IJR is rising at a faster rate than QQQ and/or declining at a slower rate.

The last time this relationship favored IJR was in early September—please refer to the chart. Between early September and early October, when this ratio peaked, IJR was up almost 10% while QQQ was up less than 1%. I am not saying that the performance disparity between Small Cap and Large Cap will be that dramatic this time. What I am saying is that the odds favor a period of outperformance by the Small Caps, as defined above, especially if the “Swamp” makes some positive inroads on tax relief before year-end.

IJR (Small Cap) relative to QQQ (technology heavy Large Cap) Chart

Have a wonderful week, and please know that Day Hagan Asset Management appreciates your support!

Art Huprich, CMT
Chief Market Technician
Day Hagan Asset Management

—Written 11.20.2017. Chart sources:

*Prices as of the close 11/17/17.

Print Copy of Article: Day Hagan Tech Talk November 20, 2017 (PDF)

Disclosure: The data and analysis contained herein are provided "as is" and without warranty of any kind, either expressed or implied. Day Hagan Asset Management (DHAM), any of its affiliates or employees, or any third-party data provider, shall not have any liability for any loss sustained by anyone who has relied on the information contained in any Day Hagan Asset Management literature or marketing materials. All opinions expressed herein are subject to change without notice, and you should always obtain current information and perform due diligence before investing. DHAM accounts that DHAM or its affiliated companies manage, or their respective shareholders, directors, officers and/or employees, may have long or short positions in the securities discussed herein and may purchase or sell such securities without notice. DHAM uses and has historically used various methods to evaluate investments which, at times, produce contradictory recommendations with respect to the same securities. When evaluating the results of prior DHAM recommendations or DHAM performance rankings, one should also consider that DHAM may modify the methods it uses to evaluate investment opportunities from time to time, that model results do not impute or show the compounded adverse effect of transactions costs or management fees or reflect actual investment results, that some model results do not reflect actual historical recommendations, and that investment models are necessarily constructed with the benefit of hindsight. For this and for many other reasons, the performance of DHAM’s past recommendations and model results are not a guarantee of future results. The securities mentioned in this document may not be eligible for sale in some states or countries, nor be suitable for all types of investors; their value and income they produce may fluctuate and/or be adversely affected by exchange rates, interest rates or other factors.

Investment advisory services offered through Day Hagan Asset Management, an SEC registered investment advisory firm. Accounts held at Raymond James and Associates, Inc. (member NYSE, SIPC). None of the entities listed here in this disclosure are affiliated.